MDT

98.64

+1.99%↑

A

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

A

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

A

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

A

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

A

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

Search

Omnicell Inc

Cerrado

SectorSanidad

48.77 -3.06

Resumen

Variación precio

24h

Actual

Mínimo

48.71

Máximo

50.61

Métricas clave

By Trading Economics

Ingresos

-177K

5.5M

Ventas

20M

311M

P/B

Media del Sector

117.488

89.037

BPA

0.51

Margen de beneficios

1.758

Empleados

3,600

EBITDA

524K

31M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+10.06% upside

Dividendos

By Dow Jones

Próximas Ganancias

5 feb 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

918M

2.3B

Apertura anterior

51.83

Cierre anterior

48.77

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

159 / 361 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Omnicell Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

20 ene 2026, 23:43 UTC

Charlas de Mercado

Gold Consolidates; May Face Technical Correction -- Market Talk

20 ene 2026, 23:42 UTC

Charlas de Mercado

Nikkei May Fall Amid Concerns Over U.S.-Europe Trade Relations -- Market Talk

20 ene 2026, 23:41 UTC

Ganancias

Netflix Revenue and Profit Rise as Subscriptions Top 325 Million -- 2nd Update

20 ene 2026, 23:29 UTC

Charlas de Mercado

RBA Rate Hike in February Would Be a Painful One -- Market Talk

20 ene 2026, 23:26 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

20 ene 2026, 23:26 UTC

Charlas de Mercado

James Hardie Appeals More as Reece's U.S. Strategy Comes Under Scrutiny -- Market Talk

20 ene 2026, 22:45 UTC

Adquisiciones, fusiones, absorciones

ACCC: Ampol-EG Deal Is First Assessment Subject to Phase 2 Review Under New Merger Control Regime

20 ene 2026, 22:45 UTC

Adquisiciones, fusiones, absorciones

ACCC Seeks Submissions in Response to Phase 2 Notice by February 4

20 ene 2026, 22:44 UTC

Adquisiciones, fusiones, absorciones

ACCC: Ampol's Offer to Sell 19 Retail Fuel Sites Doesn't Adequately Address Issues

20 ene 2026, 22:44 UTC

Adquisiciones, fusiones, absorciones

ACCC Identifies 115 EG Sites Where Deal Could Substantially Lessen Competition

20 ene 2026, 22:43 UTC

Adquisiciones, fusiones, absorciones

ACCC Says Deal Could Substantially Lessen Competition in Retail Supply of Petrol, Diesel in Several Markets in Australia

20 ene 2026, 22:43 UTC

Adquisiciones, fusiones, absorciones

Ampol's Acquisition of EG Australia to Undergo In-Depth Review by Competition Regulator

20 ene 2026, 22:27 UTC

Adquisiciones, fusiones, absorciones

Netflix Plans to Roll Out New Mobile User Interface Later This Year, Co-CEO Says

20 ene 2026, 22:25 UTC

Adquisiciones, fusiones, absorciones

Netflix Co-CEO Sees Uptick in Engagement for TV-Based Games

20 ene 2026, 22:21 UTC

Adquisiciones, fusiones, absorciones

Netflix Would Keep 45-Day Theater Release Window for Warner Bros. Films, Co-CEO Says

20 ene 2026, 22:20 UTC

Adquisiciones, fusiones, absorciones

Netflix Excited to Strengthen Warner Bros.'s Theatrical-Distribution Business, Co-CEO Says

20 ene 2026, 22:19 UTC

Adquisiciones, fusiones, absorciones

Netflix Pleased With Early Results for Podcasts, Co-CEO Says

20 ene 2026, 22:18 UTC

Ganancias

Netflix Stock Is Falling. This Is Overshadowing the Streamer's Earnings Beat. -- Barrons.com

20 ene 2026, 22:17 UTC

Adquisiciones, fusiones, absorciones

Netflix's Live Events Are Boosting Retention, Co-CEO Says

20 ene 2026, 22:16 UTC

Adquisiciones, fusiones, absorciones

Netflix Remains 'Very Excited' About Live-Events Offering, Co-CEO Says

20 ene 2026, 22:15 UTC

Adquisiciones, fusiones, absorciones

Netflix's Proposed Deal for Warner Bros. Would Protect, Create Jobs, Co-CEO Says

20 ene 2026, 22:15 UTC

Adquisiciones, fusiones, absorciones

Netflix Competes for Attention Across Streaming, Broadcast, Cable, Gaming, Social Media, Video Platforms, Co-CEO Says

20 ene 2026, 22:13 UTC

Adquisiciones, fusiones, absorciones

Netflix Co-CEO: TV Landscape Has Never Been More Competitive

20 ene 2026, 22:11 UTC

Adquisiciones, fusiones, absorciones

Netflix Confident Warner Bros. Deal Would Pass Regulatory Review, Co-CEO Says

20 ene 2026, 22:10 UTC

Adquisiciones, fusiones, absorciones

Netflix Would Leverage Global Footprint, Streaming Expertise to Improve Warner Bros.'s HBO Max Service, Co-CEO Says

20 ene 2026, 22:08 UTC

Adquisiciones, fusiones, absorciones

Netflix Won't Raise Prices During Regulatory-Review Process for Pending Warner Bros. Deal, Co-CEO Says

20 ene 2026, 22:07 UTC

Adquisiciones, fusiones, absorciones

Netflix Sees Warner Bros. as Another Mechanism to Improve Offerings, Co-CEO Says

20 ene 2026, 22:06 UTC

Ganancias

Netflix Revenue and Profit Rise as Subscriptions Top 325 Million -- Update

20 ene 2026, 22:00 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

ESG Roundup: Market Talk

20 ene 2026, 21:50 UTC

Charlas de Mercado
Ganancias

Tech, Media & Telecom Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Omnicell Inc previsión

Precio Objetivo

By TipRanks

10.06% repunte

Estimación a 12 Meses

Media 55.6 USD  10.06%

Máximo 63 USD

Mínimo 50 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Omnicell Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

5

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

24.23 / 30.44Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

159 / 361 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat